Newron Pharmaceuticals S.p.A.

Newron Pharmaceuticals S.p.A.verified

NP5.DE

Price:

$19.42

Market Cap:

$389.70M

Newron Pharmaceuticals SpA operates as a biopharmaceutical company. The company is headquartered in Bresso, Milano and currently employs 24 full-time employees. The company focuses on the discovery and development of pharmaceutical products. The firm is engaged in discovering and developing new therapies for diseases of the Central Nervous System (CNS) and pain. The firm undertakes phase III trials with safinamide molecule for the treatment of patients with Parkinson’s disease. Newron Pharmaceuticals SpA develops ralfinamide, a molecule for the treatment of neuropathic pain. Its additional projects, such as HF0220 for neuroprotection, NW-3509 for the treatment of schizophrenia, as well as pr...[Read more]

Industry

Medical - Pharmaceuticals

IPO Date

2019-07-04

Stock Exchange

XETRA

Ticker

NP5.DE

The ROE as of December 2025 (TTM) for Newron Pharmaceuticals S.p.A. (NP5.DE) is 1.67%

According to Newron Pharmaceuticals S.p.A.’s latest financial reports and current stock price. The company's current ROE is 1.67%. This represents a change of 270.38% compared to the average of 449.88% of the last 4 quarters.

Newron Pharmaceuticals S.p.A. (NP5.DE) Historical ROE (quarterly & annually)

How has NP5.DE ROE performed in the past?

The mean historical ROE of Newron Pharmaceuticals S.p.A. over the last ten years is 48.20%. The current 1.67% ROE has changed 3.36% with respect to the historical average. Over the past ten years (40 quarters), NP5.DE's ROE was at its highest in in the December 2024 quarter at 1.74%. The ROE was at its lowest in in the December 2021 quarter at -187.90%.

Quarterly (TTM)
Annual

Average

48.20%

Median

-29.02%

Minimum

-479.59%

Maximum

1.09%

Newron Pharmaceuticals S.p.A. (NP5.DE) ROE by Quarter and Year

Discovering the peaks and valleys of Newron Pharmaceuticals S.p.A. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.90%

Maximum Annual ROE = 1.09%

Minimum Annual Increase = -126.00%

Minimum Annual ROE = -479.59%

Quarterly (TTM)
Annual
YearROEChange
20241.09%1.90%
202354.25%-56.49%
2022124.68%-126.00%
2021-479.59%293.90%
2020-121.76%121.72%
2019-54.91%100.28%
2018-27.42%251.53%
2017-7.80%-74.54%
2016-30.63%-50.18%
2015-61.48%78.20%

Newron Pharmaceuticals S.p.A. (NP5.DE) Average ROE

How has NP5.DE ROE performed in the past?

The current ROE of Newron Pharmaceuticals S.p.A. (NP5.DE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

421.85%

5-year avg

132.84%

10-year avg

48.20%

Newron Pharmaceuticals S.p.A. (NP5.DE) ROE vs. Peers

How is NP5.DE’s ROE compared to its peers?

Newron Pharmaceuticals S.p.A.’s ROE is greater than Medios AG (3.66%), greater than M1 Kliniken AG (15.83%), greater than Stratec SE (6.23%), greater than High Tide Inc. (-6.78%), greater than Formycon AG (-39.02%), greater than Mediclin AG (15.26%), greater than Zura Bio Limited (-51.70%), greater than DocCheck AG (13.77%), greater than Geratherm Medical AG (8.38%), greater than Heidelberg Pharma AG (-84.55%),

CompanyROEMarket cap
3.66%$369.32M
15.83%$342.52M
6.23%$278.37M
-6.78%$189.90M
-39.02%$440.73M
15.26%$179.55M
-51.70%$214.57M
13.77%$58.35M
8.38%$16.99M
-84.55%$132.40M

Build a custom stock screener for Newron Pharmaceuticals S.p.A. (NP5.DE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Newron Pharmaceuticals S.p.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Newron Pharmaceuticals S.p.A. (NP5.DE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Newron Pharmaceuticals S.p.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Newron Pharmaceuticals S.p.A.'s ROE?

How is the ROE calculated for Newron Pharmaceuticals S.p.A. (NP5.DE)?

What is the highest ROE for Newron Pharmaceuticals S.p.A. (NP5.DE)?

What is the 3-year average ROE for Newron Pharmaceuticals S.p.A. (NP5.DE)?

What is the 5-year average ROE for Newron Pharmaceuticals S.p.A. (NP5.DE)?

How does the current ROE for Newron Pharmaceuticals S.p.A. (NP5.DE) compare to its historical average?